Business ❯ Pharmaceutical Industry ❯ Drug Development

Clinical Research

Market Impact Market Competition Partnerships Regulatory Affairs Novo Nordisk Sanofi Market Approval Market Analysis Market Performance Drug Safety Market Applications Lykos Therapeutics Workforce Management Market Withdrawal UCB SA MindMed Stock Performance Veterinary Drugs Market Competitiveness Bayer AstraZeneca Global Trials Eli Lilly and Co Market Reactions Phase 3 Trials Investment Risks Wave Life Sciences Moderna Phase III Trials Eli Lilly and Company Vaccine Development Trial Outcomes

6 ARTICLES

last wk.

Definium’s LSD-Based Therapy Posts Third Positive Phase 3 Result in GAD

The Panorama readout strengthens the company’s push toward an NDA in H1 2027 by showing a rapid, moderate clinical effect with a safety profile similar to placebo.

5 ARTICLES

2w ago

Novo Nordisk’s Semaglutide Eases Childhood Obesity as Heart-Drug Trials Are Halted

4 ARTICLES

last mo.

Tenax Therapeutics Stock Collapses After Phase 3 Levosimendan Trial Misses Endpoints

6 ARTICLES

last mo.

Novo Nordisk’s Ziltivekimab Lowers Inflammation but Fails to Reduce Major Heart Events

9 ARTICLES

4mo ago

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

4 ARTICLES

8mo ago

Sanofi Pushes Amlitelimab Toward 2026 Filings After Mixed Phase 3 Readouts

7 ARTICLES

9mo ago

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

3 ARTICLES

10mo ago

Junshi’s Subcutaneous Toripalimab Matches IV in Phase 3 NSCLC Trial as Company Prepares NDA

3 ARTICLES

11mo ago

Inhibrx Drug Extends PFS in Chondrosarcoma Phase 2 as Shares Jump Over 70%

3 ARTICLES

11mo ago

Sanofi’s Efdoralprin Alfa Shows Superior Biomarker Response to Plasma Therapy in Phase 2 AATD Trial

4 ARTICLES

11mo ago

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

3 ARTICLES

last yr.

Bristol Myers’ Iberdomide Combo Hits MRD Goal in Phase 3 Myeloma Study

3 ARTICLES

last yr.

AstraZeneca’s Fasenra Misses Primary Endpoint in COPD Phase III Trial

Clinical Research

Definium’s LSD-Based Therapy Posts Third Positive Phase 3 Result in GAD

Novo Nordisk’s Semaglutide Eases Childhood Obesity as Heart-Drug Trials Are Halted

Tenax Therapeutics Stock Collapses After Phase 3 Levosimendan Trial Misses Endpoints

Novo Nordisk’s Ziltivekimab Lowers Inflammation but Fails to Reduce Major Heart Events

Regeneron Slides as Melanoma Combo Fails to Beat Keytruda in Phase 3

Wave Life Sciences Shares Plunge 30% After Early Obesity Trial Readout

Asundexian Cuts Recurrent Stroke 26% Without More Major Bleeding in Phase III

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Sanofi Pushes Amlitelimab Toward 2026 Filings After Mixed Phase 3 Readouts

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

Never miss stories about

Clinical Research

Junshi’s Subcutaneous Toripalimab Matches IV in Phase 3 NSCLC Trial as Company Prepares NDA

Inhibrx Drug Extends PFS in Chondrosarcoma Phase 2 as Shares Jump Over 70%

Sanofi’s Efdoralprin Alfa Shows Superior Biomarker Response to Plasma Therapy in Phase 2 AATD Trial

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

Bristol Myers’ Iberdomide Combo Hits MRD Goal in Phase 3 Myeloma Study

AstraZeneca’s Fasenra Misses Primary Endpoint in COPD Phase III Trial

Never miss stories about

Clinical Research